target-drug-evidence-evaluation

Assess target drugs using a multidimensional evidence matrix and support project-level Go/No‑Go decisions. Suitable for evaluating genetic, mechanistic, clinical, competitive, patent, and safety evidence for target–indication relationships to inform Go/No‑Go judgments.